Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
3.290
+0.060 (1.86%)
Feb 13, 2026, 4:08 PM HKT
35.95% (1Y)
| Market Cap | 8.00B +26.1% |
| Revenue (ttm) | 777.75M +2.9% |
| Net Income | -68.49M |
| EPS | -0.08 |
| Shares Out | 1.04B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.07 (2.10%) |
| Ex-Dividend Date | n/a |
| Volume | 1,346,000 |
| Average Volume | 2,597,970 |
| Open | 3.280 |
| Previous Close | 3.230 |
| Day's Range | 3.260 - 3.320 |
| 52-Week Range | 2.130 - 5.290 |
| Beta | 0.13 |
| RSI | 59.36 |
| Earnings Date | Mar 31, 2026 |